These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 17222788)

  • 1. Tracking normalization of brain tumor vasculature by magnetic imaging and proangiogenic biomarkers.
    Hormigo A; Gutin PH; Rafii S
    Cancer Cell; 2007 Jan; 11(1):6-8. PubMed ID: 17222788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients.
    Batchelor TT; Sorensen AG; di Tomaso E; Zhang WT; Duda DG; Cohen KS; Kozak KR; Cahill DP; Chen PJ; Zhu M; Ancukiewicz M; Mrugala MM; Plotkin S; Drappatz J; Louis DN; Ivy P; Scadden DT; Benner T; Loeffler JS; Wen PY; Jain RK
    Cancer Cell; 2007 Jan; 11(1):83-95. PubMed ID: 17222792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased survival of glioblastoma patients who respond to antiangiogenic therapy with elevated blood perfusion.
    Sorensen AG; Emblem KE; Polaskova P; Jennings D; Kim H; Ancukiewicz M; Wang M; Wen PY; Ivy P; Batchelor TT; Jain RK
    Cancer Res; 2012 Jan; 72(2):402-7. PubMed ID: 22127927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiangiogenic therapy for glioblastoma.
    Gerstner ER; Batchelor TT
    Cancer J; 2012; 18(1):45-50. PubMed ID: 22290257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A "vascular normalization index" as potential mechanistic biomarker to predict survival after a single dose of cediranib in recurrent glioblastoma patients.
    Sorensen AG; Batchelor TT; Zhang WT; Chen PJ; Yeo P; Wang M; Jennings D; Wen PY; Lahdenranta J; Ancukiewicz M; di Tomaso E; Duda DG; Jain RK
    Cancer Res; 2009 Jul; 69(13):5296-300. PubMed ID: 19549889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Halofuginone inhibits angiogenesis and growth in implanted metastatic rat brain tumor model--an MRI study.
    Abramovitch R; Itzik A; Harel H; Nagler A; Vlodavsky I; Siegal T
    Neoplasia; 2004; 6(5):480-9. PubMed ID: 15548356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase II study of cediranib, an oral pan-vascular endothelial growth factor receptor tyrosine kinase inhibitor, in patients with recurrent glioblastoma.
    Batchelor TT; Duda DG; di Tomaso E; Ancukiewicz M; Plotkin SR; Gerstner E; Eichler AF; Drappatz J; Hochberg FH; Benner T; Louis DN; Cohen KS; Chea H; Exarhopoulos A; Loeffler JS; Moses MA; Ivy P; Sorensen AG; Wen PY; Jain RK
    J Clin Oncol; 2010 Jun; 28(17):2817-23. PubMed ID: 20458050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiangiogenic compounds interfere with chemotherapy of brain tumors due to vessel normalization.
    Claes A; Wesseling P; Jeuken J; Maass C; Heerschap A; Leenders WP
    Mol Cancer Ther; 2008 Jan; 7(1):71-8. PubMed ID: 18187807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Initial testing of the VEGFR inhibitor AZD2171 by the pediatric preclinical testing program.
    Maris JM; Courtright J; Houghton PJ; Morton CL; Gorlick R; Kolb EA; Lock R; Tajbakhsh M; Reynolds CP; Keir ST; Wu J; Smith MA
    Pediatr Blood Cancer; 2008 Mar; 50(3):581-7. PubMed ID: 17457854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiangiogenic therapy for high-grade glioma.
    Khasraw M; Ameratunga MS; Grant R; Wheeler H; Pavlakis N
    Cochrane Database Syst Rev; 2014 Sep; (9):CD008218. PubMed ID: 25242542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bevacizumab antiangiogenic therapy for glioblastoma.
    Junck L
    Neurology; 2011 Feb; 76(5):414-5. PubMed ID: 21282587
    [No Abstract]   [Full Text] [Related]  

  • 12. Antiangiogenic (metronomic) chemotherapy for brain tumors: current and future perspectives.
    Samuel DP; Wen PY; Kieran MW
    Expert Opin Investig Drugs; 2009 Jul; 18(7):973-83. PubMed ID: 19548852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiangiogenic therapy for glioblastoma: current status and future prospects.
    Batchelor TT; Reardon DA; de Groot JF; Wick W; Weller M
    Clin Cancer Res; 2014 Nov; 20(22):5612-9. PubMed ID: 25398844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of evasion to antiangiogenic therapy in glioblastoma.
    Rose SD; Aghi MK
    Clin Neurosurg; 2010; 57():123-8. PubMed ID: 21280504
    [No Abstract]   [Full Text] [Related]  

  • 15. Vascular Magnetic Resonance Imaging in Brain Tumors During Antiangiogenic Therapy--Are We There Yet?
    Gerstner ER; Emblem KE; Sorensen GA
    Cancer J; 2015; 21(4):337-42. PubMed ID: 26222087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. VEGF inhibitors in brain tumors.
    Brastianos PK; Batchelor TT
    Clin Adv Hematol Oncol; 2009 Nov; 7(11):753-60, 768. PubMed ID: 20075834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiogenesis and antiangiogenic therapy for malignant gliomas.
    Takano S; Kamiyama H; Tsuboi K; Matsumura A
    Brain Tumor Pathol; 2004; 21(2):69-73. PubMed ID: 15700836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Edema control by cediranib, a vascular endothelial growth factor receptor-targeted kinase inhibitor, prolongs survival despite persistent brain tumor growth in mice.
    Kamoun WS; Ley CD; Farrar CT; Duyverman AM; Lahdenranta J; Lacorre DA; Batchelor TT; di Tomaso E; Duda DG; Munn LL; Fukumura D; Sorensen AG; Jain RK
    J Clin Oncol; 2009 May; 27(15):2542-52. PubMed ID: 19332720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular endothelial growth factor blockade alters magnetic resonance imaging biomarkers of vascular function and decreases barrier permeability in a rat model of lung cancer brain metastasis.
    Pishko GL; Muldoon LL; Pagel MA; Schwartz DL; Neuwelt EA
    Fluids Barriers CNS; 2015 Feb; 12():5. PubMed ID: 25879723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiogenesis in gliomas: imaging and experimental therapeutics.
    Gagner JP; Law M; Fischer I; Newcomb EW; Zagzag D
    Brain Pathol; 2005 Oct; 15(4):342-63. PubMed ID: 16389946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.